Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans
- PMID: 31471173
- DOI: 10.1016/j.cmet.2019.07.016
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans
Erratum in
-
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans.Cell Metab. 2020 Apr 7;31(4):878-881. doi: 10.1016/j.cmet.2020.02.011. Cell Metab. 2020. PMID: 32268118 No abstract available.
Abstract
Caloric restriction and intermittent fasting are known to prolong life- and healthspan in model organisms, while their effects on humans are less well studied. In a randomized controlled trial study (ClinicalTrials.gov identifier: NCT02673515), we show that 4 weeks of strict alternate day fasting (ADF) improved markers of general health in healthy, middle-aged humans while causing a 37% calorie reduction on average. No adverse effects occurred even after >6 months. ADF improved cardiovascular markers, reduced fat mass (particularly the trunk fat), improving the fat-to-lean ratio, and increased β-hydroxybutyrate, even on non-fasting days. On fasting days, the pro-aging amino-acid methionine, among others, was periodically depleted, while polyunsaturated fatty acids were elevated. We found reduced levels sICAM-1 (an age-associated inflammatory marker), low-density lipoprotein, and the metabolic regulator triiodothyronine after long-term ADF. These results shed light on the physiological impact of ADF and supports its safety. ADF could eventually become a clinically relevant intervention.
Keywords: RCT; aging; body shape; caloric restriction; cardiovascular disease risk; clinical trial; fasting; fat distribution; intermittent fasting; triiodothyronine.
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment in
-
Alternate-Day Fasting Gets a Safe Bill of Health.Cell Metab. 2019 Sep 3;30(3):411-413. doi: 10.1016/j.cmet.2019.08.006. Cell Metab. 2019. PMID: 31484053
-
Safety and efficacy of alternate day fasting.Nat Rev Endocrinol. 2019 Dec;15(12):686-687. doi: 10.1038/s41574-019-0270-y. Nat Rev Endocrinol. 2019. PMID: 31558778 No abstract available.
-
Cardiovascular benefits of intermittent fasting.Cardiovasc Res. 2020 Mar 1;116(3):e36-e38. doi: 10.1093/cvr/cvaa022. Cardiovasc Res. 2020. PMID: 32077476 No abstract available.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
